Mesenchymal stem cells in ischemic tissue regeneration  

作　　者：Renata Szydlak 

机构地区：[1]Medical Biochemistry, Faculty of Medicine, Jagiellonian UniversityMedical College, Kraków 31-034, Poland

出　　处：《World Journal of Stem Cells》2023年第2期16-30,共15页世界干细胞杂志（英文版）（电子版）

摘　　要：Diseases caused by ischemia are one of the leading causes of death in the world.Current therapies for treating acute myocardial infarction,ischemic stroke,and critical limb ischemia do not complete recovery.Regenerative therapies opens new therapeutic strategy in the treatment of ischemic disorders.Mesenchymal stem cells(MSCs)are the most promising option in the field of cell-based therapies,due to their secretory and immunomodulatory abilities,that contribute to ease inflammation and promote the regeneration of damaged tissues.This review presents the current knowledge of the mechanisms of action of MSCs and their therapeutic effects in the treatment of ischemic diseases,described on the basis of data from in vitro experiments and preclinical animal studies,and also summarize the effects of using these cells in clinical trial settings.Since the obtained therapeutic benefits are not always satisfactory,approaches aimed at enhancing the effect of MSCs in regenerative therapies are presented at the end.

关 键 词：ISCHEMIA Mesenchymal stem cells Regenerative medicine Stem cell therapy Clinical applications 

分 类 号：R542.22[医药卫生—心血管疾病]